Ranitim Tablets (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
MFDS item code 201206612 · Approved 2012.08.28
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, etc.), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
This medicine is used to treat gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent gastric and duodenal ulcers caused by postoperative ulcers or the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is administered to prevent Mendelson's syndrome before anesthesia. Additionally, it is effective in improving gastric mucosal damage (erosion, bleeding, redness, swelling) associated with acute and chronic gastritis and upper gastrointestinal bleeding. This drug is widely used for various gastrointestinal diseases, protecting the gastric mucosa and aiding in the healing process.
Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medication orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage is the same when this medication is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drug use, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medication twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medication 3 times daily; the dose may be increased as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer 150 mg of this medication twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this medication 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medication once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the medication; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
For patients aged 12 years and older, administer 75 mg of this medication orally twice daily (liquid formulation only). For patients aged 8 〜 18 years, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.
This medication should not be used in patients with a history of hypersensitivity to any ingredient in this product. Patients with a history of acute porphyria may experience acute attacks if using this medication, so it should be avoided. Additionally, this product contains lactose and should not be given to patients with lactose intolerance or specific genetic metabolic disorders. Patients with impaired kidney function should use this medicine cautiously as it may accumulate in the body, requiring a dose reduction or increased dosing interval. Liver function impairment should also be monitored when administering this medication. Patients with a history of hypersensitivity to drugs, elderly patients, and those taking NSAIDs should exercise caution while using this medication. Particularly, patients over middle age who present new symptoms of gastric ulcers or dyspepsia should only be administered after excluding the possibility of gastric cancer. This medication should be used in conjunction with antibacterial treatment for gastric and duodenal ulcers caused by Helicobacter pylori infection. During the use of this medication, symptoms such as allergic reactions or shock, blood abnormalities, liver function impairment, cardiac arrhythmias, gastrointestinal symptoms, and neurological symptoms may occur. If any unusual symptoms arise, discontinue the medication immediately and consult a physician. Furthermore, this medication can cause dizziness or drowsiness, so it is advisable to avoid driving or operating hazardous machinery if such symptoms occur. When using this with other medications, be sure to inform your doctor or pharmacist as interactions may occur, and especially when used in conjunction with anticoagulants, frequent blood tests are necessary. Women who are pregnant or breastfeeding should carefully use this medication after consulting with a physician, as its safety has not been established. The safety of this medication in children has not been sufficiently verified, so caution is needed. Elderly patients may have increased blood concentrations due to decreased kidney function; therefore, dose adjustments may be necessary. Store this medication out of reach of children and avoid transferring it to other containers. While overdose symptoms are rare, treatment such as gastric lavage or hemodialysis may be necessary. Finally, this medication may promote bacterial growth in the stomach due to the reduction of gastric acid secretion, thus additional care, such as ophthalmologic examinations, is required with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it must be stored in a light-resistant container. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
White to yellowish round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.